Zai Lab Limited (ZLAB) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Zai Lab Limited  (NASDAQ: ZLAB)
 

Zai Lab Limited Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Zai Lab Limited's inventory turnover ratio sequentially decreased to 4.32 in the first quarter 2026, otherwise the ratio remained above the average, as ZLAB's markets remain strong.Zai Lab Limited's average inventory processing period in the Mar 31 2026 quarter, has increased to 84 days, from 75 days, in the Dec 31 2025 quarter.

Within Healthcare sector 136 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 1247, from total ranking in the fourth quarter 2025 at 1609.

ZLAB Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Zai Lab Limited Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZLAB Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 59.34 % 90.53 % 80.94 % 56.36 % 75.26 %
Y / Y Cost of Sales Growth -0.36 % 49.11 % 27.88 % 22.35 % 14.38 %
Inventory Turnover Ratio (TTM) 4.32 4.87 5.05 5.49 5.88
ZLAB's Total Ranking # 1247 # 1609 # 1723 # 1238 # 1207
Average inventory processing period 84 75 72 67 62
Seq. Inventory Growth 16.19 % 12.81 % 11.24 % 9.28 % 38.94 %
Seq. Cost of Sales Growth -38.5 % 33.22 % 8.75 % 11.84 % -7.97 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 33
Healthcare Sector # 137
Overall Market # 1247

Inventory Turnover Ratio Statistics
High Average Low
11.41 2.92 0.01
(Dec 31 2018)   0



ZLAB Company Profile >> Back to ZLAB Efficiency Comparisons >> Compare ZLAB Inventory Turnover Ratio to its Competitors

Financial Statements
Zai Lab Limited's Inventories $ 53 Millions Visit ZLAB's Balance sheet
Zai Lab Limited's Cost of Revenues TTM $ 190 Millions Visit ZLAB's Income Statement
What are ZLAB's Sales? Visit ZLAB's Sales by Segment

Other Inventory Turnover Ratios
Zai Lab Limited's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ZLAB's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ZLAB's Competitors
Inventory Turnover Ratio for ZLAB's Suppliers
Inventory Turnover Ratio for ZLAB's Customers

You may also want to know
ZLAB's Sales Growth Rates ZLAB's Pe Price to earnings ratio ZLAB's Receivables Turnover Ratio ZLAB's Stock Quote
ZLAB's Net Income Growth Rates ZLAB's Ps Price to Sales ratio ZLAB's Sales per Employee ZLAB's Asset Turnover Ratio
ZLAB's Net Margin ZLAB's Pb Price to Book ratio ZLAB's Financial Strength Ratios ZLAB's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Lantheus Holdings Inc   9.75 $ 610.000  Millions$ 63  Millions
Sotera Health Company  9.58 $ 531.000  Millions$ 55  Millions
Warby Parker Inc   9.23 $ 415.000  Millions$ 45  Millions
National Vision Holdings Inc   8.90 $ 833.415  Millions$ 94  Millions
Myriad Genetics Inc   8.35 $ 248.000  Millions$ 30  Millions
Pulse Biosciences Inc   8.08 $ 0.909  Millions$ 0  Millions
Castle Biosciences Inc   7.97 $ 75.178  Millions$ 9  Millions
Moderna Inc   7.96 $ 1,733.000  Millions$ 218  Millions
Carlsmed Inc   7.95 $ 12.557  Millions$ 2  Millions
Inogen Inc   7.80 $ 195.741  Millions$ 25  Millions
Cardiff Lexington Corporation  7.70 $ 4.159  Millions$ 1  Millions
Novavax inc   7.67 $ 89.620  Millions$ 12  Millions
Prophase Labs Inc   7.64 $ 2.361  Millions$ 0  Millions
Bellevue Life Sciences Acquisition Corp  7.62 $ 1.986  Millions$ 0  Millions
Lifemd Inc   7.60 $ 24.000  Millions$ 3  Millions
Tarsus Pharmaceuticals Inc   7.60 $ 31.627  Millions$ 4  Millions
Charles River Laboratories International inc   7.56 $ 2,346.239  Millions$ 310  Millions
Adaptive Biotechnologies Corporation  7.43 $ 73.088  Millions$ 10  Millions
Puma Biotechnology Inc   7.19 $ 58.025  Millions$ 8  Millions
Fonar Corporation  7.06 $ 19.685  Millions$ 3  Millions
Carlisle Companies Incorporated  6.71 $ 3,206.100  Millions$ 478  Millions
Hims and Hers Health Inc   6.58 $ 670.000  Millions$ 102  Millions
Vanda Pharmaceuticals Inc   6.54 $ 12.682  Millions$ 2  Millions
Twist Bioscience Corporation  6.50 $ 196.251  Millions$ 30  Millions
Phathom Pharmaceuticals Inc   6.48 $ 30.871  Millions$ 5  Millions
Precision Optics Corporation Inc   6.47 $ 24.932  Millions$ 4  Millions
Nuo Therapeutics Inc   6.42 $ 1.331  Millions$ 0  Millions
Collegium Pharmaceutical Inc   6.41 $ 256.071  Millions$ 40  Millions
Veracyte Inc   6.05 $ 132.000  Millions$ 22  Millions
Kewaunee Scientific Corporation  5.98 $ 200.155  Millions$ 33  Millions

Date modified: 2026-07-07T14:27:52+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.